194 related articles for article (PubMed ID: 25319180)
1. Mucins in lung cancer: diagnostic, prognostic, and therapeutic implications.
Lakshmanan I; Ponnusamy MP; Macha MA; Haridas D; Majhi PD; Kaur S; Jain M; Batra SK; Ganti AK
J Thorac Oncol; 2015 Jan; 10(1):19-27. PubMed ID: 25319180
[TBL] [Abstract][Full Text] [Related]
2. MUC4 expression correlates with poor prognosis in small-sized lung adenocarcinoma.
Tsutsumida H; Goto M; Kitajima S; Kubota I; Hirotsu Y; Wakimoto J; Batra SK; Imai K; Yonezawa S
Lung Cancer; 2007 Feb; 55(2):195-203. PubMed ID: 17126950
[TBL] [Abstract][Full Text] [Related]
3. CD44 and its v6 spliced variant in lung carcinomas: relation to NCAM, CEA, EMA and UP1 and prognostic significance.
Nguyen VN; Mirejovský T; Melinová L; Mandys V
Neoplasma; 2000; 47(6):400-8. PubMed ID: 11263866
[TBL] [Abstract][Full Text] [Related]
4. Pathological Implications of Mucin Signaling in Metastasis.
Dhanisha SS; Guruvayoorappan C
Curr Cancer Drug Targets; 2023; 23(8):585-602. PubMed ID: 36941808
[TBL] [Abstract][Full Text] [Related]
5. Comprehensive analysis of the mechanism and treatment significance of Mucins in lung cancer.
Ning Y; Zheng H; Zhan Y; Liu S; Yang Y; Zang H; Luo J; Wen Q; Fan S
J Exp Clin Cancer Res; 2020 Aug; 39(1):162. PubMed ID: 32807223
[TBL] [Abstract][Full Text] [Related]
6. Sialomucin expression is associated with erbB-2 oncoprotein overexpression, early recurrence, and cancer death in non-small-cell lung cancer.
Yu CJ; Shun CT; Yang PC; Lee YC; Shew JY; Kuo SH; Luh KT
Am J Respir Crit Care Med; 1997 Apr; 155(4):1419-27. PubMed ID: 9105088
[TBL] [Abstract][Full Text] [Related]
7. The impact of intracytoplasmic mucin in lung adenocarcinoma with pneumonic radiological presentation.
Duruisseaux M; Antoine M; Rabbe N; Poulot V; Fleury-Feith J; Vieira T; Lavolé A; Cadranel J; Wislez M
Lung Cancer; 2014 Mar; 83(3):334-40. PubMed ID: 24461303
[TBL] [Abstract][Full Text] [Related]
8. MUC20 overexpression predicts poor prognosis and enhances EGF-induced malignant phenotypes via activation of the EGFR-STAT3 pathway in endometrial cancer.
Chen CH; Wang SW; Chen CW; Huang MR; Hung JS; Huang HC; Lin HH; Chen RJ; Shyu MK; Huang MC
Gynecol Oncol; 2013 Mar; 128(3):560-7. PubMed ID: 23262208
[TBL] [Abstract][Full Text] [Related]
9. Aberrant expression of transmembrane mucins, MUC1 and MUC4, in human prostate carcinomas.
Singh AP; Chauhan SC; Bafna S; Johansson SL; Smith LM; Moniaux N; Lin MF; Batra SK
Prostate; 2006 Mar; 66(4):421-9. PubMed ID: 16302265
[TBL] [Abstract][Full Text] [Related]
10. Correlation between mucin biology and tumor heterogeneity in lung cancer.
Xu M; Wang DC; Wang X; Zhang Y
Semin Cell Dev Biol; 2017 Apr; 64():73-78. PubMed ID: 27569189
[TBL] [Abstract][Full Text] [Related]
11. The membrane-bound mucins: From cell signalling to transcriptional regulation and expression in epithelial cancers.
Jonckheere N; Van Seuningen I
Biochimie; 2010 Jan; 92(1):1-11. PubMed ID: 19818375
[TBL] [Abstract][Full Text] [Related]
12. Expression of sialylated MUC1 in prostate cancer: relationship to clinical stage and prognosis.
Arai T; Fujita K; Fujime M; Irimura T
Int J Urol; 2005 Jul; 12(7):654-61. PubMed ID: 16045558
[TBL] [Abstract][Full Text] [Related]
13. Expression of MUC1 and MUC2 mucins in epithelial ovarian tumours.
Dong Y; Walsh MD; Cummings MC; Wright RG; Khoo SK; Parsons PG; McGuckin MA
J Pathol; 1997 Nov; 183(3):311-7. PubMed ID: 9422987
[TBL] [Abstract][Full Text] [Related]
14. The expression of several types of mucin is related to the biological behavior of pancreatic neoplasms.
Yonezawa S; Nakamura A; Horinouchi M; Sato E
J Hepatobiliary Pancreat Surg; 2002; 9(3):328-41. PubMed ID: 12353144
[TBL] [Abstract][Full Text] [Related]
15. Expression of targeting protein for xklp2 associated with both malignant transformation of respiratory epithelium and progression of squamous cell lung cancer.
Ma Y; Lin D; Sun W; Xiao T; Yuan J; Han N; Guo S; Feng X; Su K; Mao Y; Cheng S; Gao Y
Clin Cancer Res; 2006 Feb; 12(4):1121-7. PubMed ID: 16489064
[TBL] [Abstract][Full Text] [Related]
16. Combined evaluation of mucin antigen and E-cadherin expression may help select patients with gastric cancer suitable for minimally invasive therapy.
Tanaka M; Kitajima Y; Sato S; Miyazaki K
Br J Surg; 2003 Jan; 90(1):95-101. PubMed ID: 12520583
[TBL] [Abstract][Full Text] [Related]
17. Expression of MUC1 and MUC2 mucins in gastric carcinomas: its relationship with the prognosis of the patients.
Utsunomiya T; Yonezawa S; Sakamoto H; Kitamura H; Hokita S; Aiko T; Tanaka S; Irimura T; Kim YS; Sato E
Clin Cancer Res; 1998 Nov; 4(11):2605-14. PubMed ID: 9829723
[TBL] [Abstract][Full Text] [Related]
18. Mucins as immunogenic targets in cancer.
Syrigos KN; Karayiannakis AJ; Zbar A
Anticancer Res; 1999; 19(6B):5239-44. PubMed ID: 10697542
[TBL] [Abstract][Full Text] [Related]
19. Mucins in pancreatic cancer and its microenvironment.
Kaur S; Kumar S; Momi N; Sasson AR; Batra SK
Nat Rev Gastroenterol Hepatol; 2013 Oct; 10(10):607-20. PubMed ID: 23856888
[TBL] [Abstract][Full Text] [Related]
20. Mucins and CD56 as markers of tumour invasion and prognosis in periampullary cancer.
Aloysius MM; Zaitoun AM; Awad S; Ilyas M; Rowlands BJ; Lobo DN
Br J Surg; 2010 Aug; 97(8):1269-78. PubMed ID: 20602499
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
